Skip to main content
Renal-Cell Carcinoma
Nivolumab Rechallenge Associated with Moderate Efficacy
Read More
Renal-Cell Carcinoma
Stereotactic Radiotherapy Delays Treatment Switch in Those with Oligoprogression
Read More
Renal-Cell Carcinoma
Study 218: Higher Lenvatinib Starting Dose Trended Toward Better Outcomes
Read More
Renal-Cell Carcinoma
BREAKPOINT: Cabozantinib Efficacious After Treatment with First-Line Immunotherapy
Read More
Renal-Cell Carcinoma
Renal-Cell Carcinoma Year in Review Introduction
Read More
Renal-Cell Carcinoma
COSMIC-021: Antitumor Activity with Cabozantinib plus Atezolizumab for Clear-Cell and Non–Clear-Cell Renal-Cell Carcinoma
Read More
Renal-Cell Carcinoma
Belzutifan Shows Promise as a Novel Option for Advanced Renal-Cell Carcinoma
Read More
Renal-Cell Carcinoma
IMmotion150: Atezolizumab plus Bevacizumab Safe and Efficacious in Pretreated Disease
Read More
Renal-Cell Carcinoma
KEYNOTE-146: Lenvatinib plus Pembrolizumab Tolerable and Effective in Treatment-Naïve and Previously Treated Patients with RCC
Read More
Renal-Cell Carcinoma
TIVO-3: Post-Hoc and Subgroup Analyses of Third- and Fourth-Line Tivozanib Treatment Compared with Sorafenib
Read More
Page 64 of 196
Results 631 - 640 of 1953